The importance of surgical staging in the treatment of malignant pleural mesothelioma

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 4, 1996, Pages 815-826

  Rusch, V W ^a   Venkatraman, E ^a   Mathisen, D J ^a   DeCamp, M M ^a   Ginsberg, R J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECORTICATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROGNOSIS; THORACOTOMY;

EID: 0029873998     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70342-2     Document Type: Article

References (36)

1. NV Dimitrov S McMahon Presentation, diagnostic methods, staging, and natural history of malignant mesothelioma K Antman J Aisner Asbestos-related malignancy 1987 : Grune & Stratton Orlando 225 238
2. AP. Chahinian Therapeutic modalities in malignant pleural mesothelioma J Chretien A Hirsch Diseases of the pleura. 1983 : Masson New York 224 236
3. DJ Sugarbaker GM Strauss TJ Lynch Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma J Clin Oncol 11 1993 1172 1178
4. EG Butchart T Ashcroft WC Barnsley MP. Holden Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients Thorax 31 1976 15 24
5. K. Mattson Natural history and clinical staging of malignant mesothelioma [Abstract] Eur J Respir Dis 63 Suppl 124 1982 87
6. VW Rusch RJ. Ginsberg New concepts in the staging of mesotheliomas J Deslauriers LK Lacquet Thoracic surgery: surgical management of pleural diseases 1990 : Mosby St. Louis 336 343
7. Rusch VW, The International Mesothelioma Interest Group. a proposed new international TNM staging system for malignant pleural mesothelioma. Chest [In press].
8. VW Rusch D. Dillard Pleural mesothelioma FG Pearson J Deslauriers RJ Ginsberg CA Hiebert MF McKneally HC Urschel Thoracic surgery. 1995 : Churchill Livingstone New York 1083 1105
9. VW Rusch S Piantadosi EC Holmes The role of extrapleural pneumonectomy in malignant pleural mesothelioma J THORAC CARDIOVASC SURG 102 1991 1 9
10. VW Rusch L Saltz E Venkatraman A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 1994 1156 1163
11. V Rusch R. Livingston Radical decortication, intraoperative intrapleural cisplatin (CDDP) and post-operative systemic chemotherapy for malignant pleural mesothelioma (MM) [Abstract] Proc Am Soc Clin Oncol 8 1989 219
12. EL Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
13. N Mantel W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1958 718 748
14. DR. Cox Regression models and life tables [with discussion] J R Stat Soc B 34 1972 187 220
15. JC Wagner CA Slegg P. Marchand Diffuse pleural mesotheliomas and asbestos exposure in Northwestern Cape Province Br J Ind Med 17 1960 260 271
16. R Spirtas RR Connelly MA. Tucker Survival patterns for malignant mesothelioma: the SEER experience Int J Cancer 41 1988 525 530
17. JC. Wagner Mesothelioma and mineral fibers Cancer 57 1986 1905 1911
18. VI Adams KK Unni JR Muhm JR Jett DM Ilstrup PE. Bernatz Diffuse malignant mesothelioma of pleura: diagnosis and survival in 92 cases Cancer 58 1986 1540 1551
19. RJ Nauta RT Osteen KH Antman JK. Koster Clinical staging and the tendency of malignant pleural mesotheliomas to remain localized Ann Thorac Surg 34 1982 66 70
20. PR Wirth J Legier GL Wright Jr. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma Cancer 67 1991 655 662
21. MR Law A Gregor ME Hodson HJG Bloom M. Turner-Warwick Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients Thorax 39 1984 255 259
22. RJ Lewis GE Sisler JW. Mackenzie Diffuse, mixed malignant pleural mesothelioma Ann Thorac Surg 31 1981 53 60
23. AS Alberts G Falkson L Goedhals DA Vorobiof CA. Van Der Merwe Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers J Clin Oncol 6 1988 527 535
24. R Achatzy W Beba R Ritschler The diagnosis, therapy and prognosis of diffuse malignant mesothelioma Eur J Cardiothorac Surg 3 1989 445 448
25. G Hulks JStJ Thomas E. Waclawski Malignant pleural mesothelioma in western Glasgow 1980-6 Thorax 44 1989 496 500
26. KB Allen LP Faber WH. Warren Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy Chest Surg Clin North Am 4 1994 113 126
27. C Boutin F. Rey Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis Cancer 72 1993 389 393
28. C Boutin F Rey J Gouvernet J-R Viallat P Astoul V. Ledoray Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging Cancer 72 1993 394 404
29. DJ Sugarbaker EC Heher TH Lee extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma J THORAC CARDIOVASC SURG 102 1991 10 15
30. P. Maasilta Deterioration in lung function following hemithorax irradiation for pleural mesothelioma Int J Radiation Oncol Biol Physiol 20 1991 433 438
31. BR Mychalczak D Nori JG Armstrong N Martini LB. Harrison Results of treatment of malignant pleural mesothelioma with surgery, brachytherapy, and external beam irradiation [Abstract] Proceedings of the American Endocurietherapy Society 1989 12
32. L. Tammilehto Malignant mesothelioma: prognostic factors in a prospective study of 98 patients Lung Cancer 8 1992 175 184
33. Pogrebniak H, Temeck B, Steinberg S, Kranda K, Pass H. Cisplatin, interferon, and tamoxifen for primary and adjuvant use in malignant pleural mesothelioma. Ann Surg Oncol [In press].
34. R Ruffie R Feld S Minkin Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients J Clin Oncol 7 1989 1157 1168
35. KH Antman R Shemin L Ryan Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985 J Clin Oncol 6 1988 147 153
36. AP Chahinian TF Pajak JF Holland L. Norton Diffuse malignant mesothelioma: prospective evaluation of 69 patients Ann Intern Med 96 6, Pt 1 1982 746 755